Viewing Study NCT04401293


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-02-07 @ 11:29 PM
Study NCT ID: NCT04401293
Status: COMPLETED
Last Update Posted: 2021-11-22
First Post: 2020-05-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients
Sponsor: Northwell Health
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sars-CoV2 View
None COVID View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None Anticoagulation View
None Heparin View
None Coronavirus View
None Thrombosis View